Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.57	4.28	4.51	7.82	8.32	8.34
Cash & Short-Term Investments	4.57	4.28	4.51	7.82	8.32	8.34
Cash Growth	-14.44%	-4.99%	-42.36%	-5.96%	-0.22%	1.98%
Accounts Receivable	12.83	16.1	16.71	21.83	17.77	20.7
Receivables	12.83	16.1	16.71	21.83	17.77	20.7
Inventory	25.99	24.72	26.44	27.59	22.26	22.06
Other Current Assets	3.4	3.94	3.47	4.34	3.36	2.47
Total Current Assets	46.79	49.04	51.12	61.58	51.7	53.57
Property, Plant & Equipment	11.74	8.75	9.18	10.31	11.72	13.24
Goodwill	57.44	57.07	56.26	57.69	58.59	57.38
Other Intangible Assets	12.34	16.04	21.01	27.39	33.15	38.41
Long-Term Deferred Tax Assets	-	0.44	0.33	0.21	0.26	0.25
Other Long-Term Assets	2.92	6.04	7.45	5.17	0.84	2.02
Total Assets	131.24	137.37	145.36	162.34	156.25	164.87
Accounts Payable	5.28	5.55	6.45	4.91	5.97	5.34
Accrued Expenses	2.73	4.43	3.87	6.53	4.15	3.37
Current Portion of Long-Term Debt	3.61	5.86	3.81	3.24	1.72	6.9
Current Portion of Leases	1.13	1.42	2.14	2.14	2.11	2.42
Current Income Taxes Payable	-	-	-	0.22	0.29	0.61
Current Unearned Revenue	3.69	4.51	3.37	4.27	3.77	3.95
Other Current Liabilities	6.32	4.78	3.62	4.01	3.05	2.72
Total Current Liabilities	22.75	26.54	23.25	25.32	21.05	25.31
Long-Term Debt	34.48	30.7	43.01	45.1	46.29	47.52
Long-Term Leases	6.71	4.79	5.28	6.49	7.48	8.22
Long-Term Deferred Tax Liabilities	0.71	0.78	0.59	1.56	1.9	1.97
Other Long-Term Liabilities	1.28	1.48	1.01	0.49	1.26	0.15
Total Liabilities	65.92	64.29	73.14	78.94	79.57	83.18
Common Stock	0.44	0.43	0.45	0.45	0.44	0.44
Additional Paid-In Capital	235.97	232.44	229.01	225.65	232.36	229.19
Retained Earnings	-158.03	-145.61	-142.19	-132.67	-132.39	-124.58
Treasury Stock	-	-	-	-	-10.67	-10.67
Comprehensive Income & Other	-13.06	-14.19	-15.05	-10.03	-13.07	-12.69
Shareholders' Equity	65.32	73.07	72.22	83.4	76.68	81.69
Total Liabilities & Equity	131.24	137.37	145.36	162.34	156.25	164.87
Total Debt	45.91	42.77	54.24	56.96	57.6	65.07
Net Cash (Debt)	-41.35	-38.49	-49.73	-49.14	-49.28	-56.73
Net Cash Per Share	-0.96	-0.91	-1.20	-1.22	-1.28	-1.50
Filing Date Shares Outstanding	43.62	43.4	42.19	41.23	39.83	38.35
Total Common Shares Outstanding	43.62	43.39	42.08	41.14	39.41	38.19
Working Capital	24.04	22.5	27.88	36.27	30.65	28.26
Book Value Per Share	1.50	1.68	1.72	2.03	1.95	2.14
Tangible Book Value	-4.46	-0.03	-5.05	-1.67	-15.06	-14.09
Tangible Book Value Per Share	-0.10	-0.00	-0.12	-0.04	-0.38	-0.37
Machinery	-	15.95	15.71	15.3	18.02	17.57
Leasehold Improvements	-	2.42	2.51	2.56	2.54	2.15

Source: S&P Capital IQ. Standard template. Financial Sources.